Skip to main content
. 2006 Sep 15;2(9):e92. doi: 10.1371/journal.ppat.0020092

Figure 4. Pretreatment Plasma Levels of sVEGFR-3 in Filaria-Infected Patients and Endemic Controls.

Figure 4

Plasma concentrations (mean ± SD) of sVEGFR-3 were measured using a commercial kit from plasma of lymphedema patients (n = 26), microfilaremic patients (n = 76), and endemic controls (n = 23, who did not have filarial infection). Mean plasma levels of sVEGFR-3 were significantly elevated in the microfilaremic (p = 0.0006) and lymphedema patients (p = 0.0012) compared to endemic controls (Student t-test with Bonferroni/Dunn correction). sVEGFR-3 was also significantly elevated in lymphedema patients (p = 0.0024) compared to microfilaremic patients.